SCHEMBL30893384

SCHEMBL30893384

Cc1c(-c2noc(C3CC3)c2C(=O)OCc2ccccc2)c2c(Cl)ncnc2n1C1CCCC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LCK P06239 2/20 0.38
▸ KDR P35968 2/20 0.38
▸ TEK Q02763 1/20 0.38
▸ NR1H4 Q96RI1 15/20 0.38
▸ ROCK2 O75116 1/20 0.38
▸ CHEK2 O96017 1/20 0.38
▸ INSR P06213 1/20 0.38
▸ FYN P06241 1/20 0.38
▸ CSF1R P07333 1/20 0.38
▸ LYN P07948 1/20 0.38
▸ IGF1R P08069 1/20 0.38
▸ KIT P10721 1/20 0.38
▸ PIM1 P11309 1/20 0.38
▸ FGFR1 P11362 1/20 0.38
▸ SRC P12931 1/20 0.38
▸ FLT1 P17948 1/20 0.38
▸ MARK3 P27448 1/20 0.38
▸ FLT4 P35916 1/20 0.38
▸ FLT3 P36888 1/20 0.38
▸ CSNK1D P48730 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29182326 1.00 LCK (0.38) LCKKDRTEKNR1H4ROCK2
SCHEMBL30893379 0.89 NR1H4 (0.37) LCKKDRTEKNR1H4FABP1
SCHEMBL29182317 0.89 NR1H4 (0.37) LCKKDRTEKNR1H4FABP1
SCHEMBL29182329 0.87 RET (0.49) NR1H4RETFTOFABP1
SCHEMBL30893390 0.87 RET (0.49) NR1H4RETFTOFABP1
SCHEMBL29182324 0.85 RET (0.41) NR1H4RETFABP1FABP4
SCHEMBL30893380 0.85 RET (0.38) NR1H4RET
SCHEMBL29182337 0.85 RET (0.38) NR1H4RET
SCHEMBL30341063 0.85 RET (0.41) NR1H4RETFABP1FABP4
SCHEMBL30341066 0.83 DGAT1 (0.37) NR1H4RETFTOFABP1FABP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117813308-A Nitrogen-containing condensed ring compound, preparation method and medical application thereof 中国医药研究开发中心有限公司 2024-04-02 — — CN disclosed
Send feedback